Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib

Patients with non‐small cell lung cancer (NSCLC) and uncommon epidermal growth factor receptor (EGFR) mutation are characterized by high heterogeneity, and globally considered to have a worse prognosis than patients with the two common mutations; exon 19 deletion, and exon 21 L858R. Nevertheless, so...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Longo, Vito, Catino, Annamaria, Montrone, Michele, Pizzutilo, Pamela, Pesola, Francesco, Marech, Ilaria, Capone, Iolanda, Prelaj, Arsela, Galetta, Domenico
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2021
Soggetti:
Case Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258364/
https://ncbi.nlm.nih.gov/pubmed/34008923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13953
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi